Role of hypoxia in cancer therapy by regulating the tumor microenvironment

X **g, F Yang, C Shao, K Wei, M **e, H Shen, Y Shu - Molecular cancer, 2019 - Springer
Aim Clinical resistance is a complex phenomenon in major human cancers involving
multifactorial mechanisms, and hypoxia is one of the key components that affect the cellular …

[HTML][HTML] MYC as a target for cancer treatment

MJ Duffy, S O'Grady, M Tang, J Crown - Cancer treatment reviews, 2021 - Elsevier
The MYC gene which consists of 3 paralogs, C-MYC, N-MYC and L-MYC, is one of the most
frequently deregulated driver genes in human cancer. Because of its high prevalence of …

A probabilistic classification tool for genetic subtypes of diffuse large B cell lymphoma with therapeutic implications

GW Wright, JD Phelan, ZA Coulibaly, S Roulland… - Cancer cell, 2020 - cell.com
The development of precision medicine approaches for diffuse large B cell lymphoma
(DLBCL) is confounded by its pronounced genetic, phenotypic, and clinical heterogeneity …

MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies

SE Ahmadi, S Rahimi, B Zarandi, R Chegeni… - Journal of hematology & …, 2021 - Springer
MYC oncogene is a transcription factor with a wide array of functions affecting cellular
activities such as cell cycle, apoptosis, DNA damage response, and hematopoiesis. Due to …

NUSAP1-LDHA-Glycolysis-Lactate feedforward loop promotes Warburg effect and metastasis in pancreatic ductal adenocarcinoma

M Chen, K Cen, Y Song, X Zhang, YC Liou, P Liu… - Cancer letters, 2023 - Elsevier
Pancreatic ductal adenocarcinoma (PDAC) is characterized by hypoxia and hypovascular
tumor microenvironment. Nucleolar and spindle associated protein 1 (NUSAP1) is a …

MYC: a complex problem

SK Das, BA Lewis, D Levens - Trends in cell biology, 2023 - cell.com
The MYC protooncogene functions as a universal amplifier of transcription through
interaction with numerous factors and complexes that regulate almost every cellular process …

[HTML][HTML] lncRNA epigenetic landscape analysis identifies EPIC1 as an oncogenic lncRNA that interacts with MYC and promotes cell-cycle progression in cancer

Z Wang, B Yang, M Zhang, W Guo, Z Wu, Y Wang, L Jia… - Cancer cell, 2018 - cell.com
We characterized the epigenetic landscape of genes encoding long noncoding RNAs
(lncRNAs) across 6,475 tumors and 455 cancer cell lines. In stark contrast to the CpG island …

TM4SF1 promotes EMT and cancer stemness via the Wnt/β-catenin/SOX2 pathway in colorectal cancer

Q Tang, J Chen, Z Di, W Yuan, Z Zhou, Z Liu… - Journal of Experimental …, 2020 - Springer
Background Transmembrane 4 L six family member 1 (TM4SF1) is upregulated in several
epithelial cancers and is closely associated with poor prognosis. However, the role of …

MYC, metabolism, and cancer

ZE Stine, ZE Walton, BJ Altman, AL Hsieh… - Cancer …, 2015 - aacrjournals.org
The MYC oncogene encodes a transcription factor, MYC, whose broad effects make its
precise oncogenic role enigmatically elusive. The evidence to date suggests that MYC …

Regulation of mammalian nucleotide metabolism and biosynthesis

AN Lane, TWM Fan - Nucleic acids research, 2015 - academic.oup.com
Nucleotides are required for a wide variety of biological processes and are constantly
synthesized de novo in all cells. When cells proliferate, increased nucleotide synthesis is …